ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1RA Therapy Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-13G16300
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GLP 1RA Therapy Market Research Report 2023
BUY CHAPTERS

Global GLP-1RA Therapy Market Research Report 2025

Code: QYRE-Auto-13G16300
Report
June 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lily
GSK
Shanghai Benemae Pharmaceutical
Hansoh Pharmaceutical
Sanofi
Astrazeneca plc
Novo Nordisk

GLP-1RA Therapy Market Size

The global market for GLP-1RA Therapy was valued at US$ 27280 million in the year 2024 and is projected to reach a revised size of US$ 44370 million by 2031, growing at a CAGR of 7.3% during the forecast period.

GLP-1RA Therapy Market

GLP-1RA Therapy Market

GLP-1RA stands for Glucagon-Like Peptide-1 Receptor Agonist. It is a type of medication used in the treatment of type 2 diabetes. GLP-1 is a hormone that is naturally produced in the gut in response to food intake. It stimulates insulin release from the pancreas, reduces the secretion of glucagon (another hormone that raises blood sugar), slows down gastric emptying, and promotes a feeling of fullness.
North American market for GLP-1RA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GLP-1RA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GLP-1RA Therapy include Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Shanghai Benemae Pharmaceutical, Hansoh Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1RA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1RA Therapy.
The GLP-1RA Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1RA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1RA Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP-1RA Therapy Market Report

Report Metric Details
Report Name GLP-1RA Therapy Market
Accounted market size in year US$ 27280 million
Forecasted market size in 2031 US$ 44370 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Short-acting GLP-1RA
  • Long-acting GLP-1RA
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Shanghai Benemae Pharmaceutical, Hansoh Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1RA Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1RA Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is GLP-1RA Therapy Market growing?

Ans: The GLP-1RA Therapy Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the GLP-1RA Therapy Market size in 2031?

Ans: The GLP-1RA Therapy Market size in 2031 will be US$ 44370 million.

Who are the main players in the GLP-1RA Therapy Market report?

Ans: The main players in the GLP-1RA Therapy Market are Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Shanghai Benemae Pharmaceutical, Hansoh Pharmaceutical

What are the Application segmentation covered in the GLP-1RA Therapy Market report?

Ans: The Applications covered in the GLP-1RA Therapy Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the GLP-1RA Therapy Market report?

Ans: The Types covered in the GLP-1RA Therapy Market report are Short-acting GLP-1RA, Long-acting GLP-1RA

1 GLP-1RA Therapy Market Overview
1.1 Product Definition
1.2 GLP-1RA Therapy by Type
1.2.1 Global GLP-1RA Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Short-acting GLP-1RA
1.2.3 Long-acting GLP-1RA
1.3 GLP-1RA Therapy by Application
1.3.1 Global GLP-1RA Therapy Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global GLP-1RA Therapy Market Size Estimates and Forecasts
1.4.1 Global GLP-1RA Therapy Revenue 2020-2031
1.4.2 Global GLP-1RA Therapy Sales 2020-2031
1.4.3 Global GLP-1RA Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GLP-1RA Therapy Market Competition by Manufacturers
2.1 Global GLP-1RA Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1RA Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1RA Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1RA Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1RA Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1RA Therapy, Product Type & Application
2.7 Global Key Manufacturers of GLP-1RA Therapy, Date of Enter into This Industry
2.8 Global GLP-1RA Therapy Market Competitive Situation and Trends
2.8.1 Global GLP-1RA Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1RA Therapy Players Market Share by Revenue
2.8.3 Global GLP-1RA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1RA Therapy Market Scenario by Region
3.1 Global GLP-1RA Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1RA Therapy Sales by Region: 2020-2031
3.2.1 Global GLP-1RA Therapy Sales by Region: 2020-2025
3.2.2 Global GLP-1RA Therapy Sales by Region: 2026-2031
3.3 Global GLP-1RA Therapy Revenue by Region: 2020-2031
3.3.1 Global GLP-1RA Therapy Revenue by Region: 2020-2025
3.3.2 Global GLP-1RA Therapy Revenue by Region: 2026-2031
3.4 North America GLP-1RA Therapy Market Facts & Figures by Country
3.4.1 North America GLP-1RA Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1RA Therapy Sales by Country (2020-2031)
3.4.3 North America GLP-1RA Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1RA Therapy Market Facts & Figures by Country
3.5.1 Europe GLP-1RA Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1RA Therapy Sales by Country (2020-2031)
3.5.3 Europe GLP-1RA Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1RA Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1RA Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1RA Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1RA Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1RA Therapy Market Facts & Figures by Country
3.7.1 Latin America GLP-1RA Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1RA Therapy Sales by Country (2020-2031)
3.7.3 Latin America GLP-1RA Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1RA Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1RA Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1RA Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1RA Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1RA Therapy Sales by Type (2020-2031)
4.1.1 Global GLP-1RA Therapy Sales by Type (2020-2025)
4.1.2 Global GLP-1RA Therapy Sales by Type (2026-2031)
4.1.3 Global GLP-1RA Therapy Sales Market Share by Type (2020-2031)
4.2 Global GLP-1RA Therapy Revenue by Type (2020-2031)
4.2.1 Global GLP-1RA Therapy Revenue by Type (2020-2025)
4.2.2 Global GLP-1RA Therapy Revenue by Type (2026-2031)
4.2.3 Global GLP-1RA Therapy Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1RA Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1RA Therapy Sales by Application (2020-2031)
5.1.1 Global GLP-1RA Therapy Sales by Application (2020-2025)
5.1.2 Global GLP-1RA Therapy Sales by Application (2026-2031)
5.1.3 Global GLP-1RA Therapy Sales Market Share by Application (2020-2031)
5.2 Global GLP-1RA Therapy Revenue by Application (2020-2031)
5.2.1 Global GLP-1RA Therapy Revenue by Application (2020-2025)
5.2.2 Global GLP-1RA Therapy Revenue by Application (2026-2031)
5.2.3 Global GLP-1RA Therapy Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1RA Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1RA Therapy Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca GLP-1RA Therapy Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lily
6.3.1 Eli Lily Company Information
6.3.2 Eli Lily Description and Business Overview
6.3.3 Eli Lily GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lily GLP-1RA Therapy Product Portfolio
6.3.5 Eli Lily Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK GLP-1RA Therapy Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi GLP-1RA Therapy Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Shanghai Benemae Pharmaceutical
6.6.1 Shanghai Benemae Pharmaceutical Company Information
6.6.2 Shanghai Benemae Pharmaceutical Description and Business Overview
6.6.3 Shanghai Benemae Pharmaceutical GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Benemae Pharmaceutical GLP-1RA Therapy Product Portfolio
6.6.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates
6.7 Hansoh Pharmaceutical
6.7.1 Hansoh Pharmaceutical Company Information
6.7.2 Hansoh Pharmaceutical Description and Business Overview
6.7.3 Hansoh Pharmaceutical GLP-1RA Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hansoh Pharmaceutical GLP-1RA Therapy Product Portfolio
6.7.5 Hansoh Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1RA Therapy Industry Chain Analysis
7.2 GLP-1RA Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1RA Therapy Production Mode & Process Analysis
7.4 GLP-1RA Therapy Sales and Marketing
7.4.1 GLP-1RA Therapy Sales Channels
7.4.2 GLP-1RA Therapy Distributors
7.5 GLP-1RA Therapy Customer Analysis
8 GLP-1RA Therapy Market Dynamics
8.1 GLP-1RA Therapy Industry Trends
8.2 GLP-1RA Therapy Market Drivers
8.3 GLP-1RA Therapy Market Challenges
8.4 GLP-1RA Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lily
GSK
Shanghai Benemae Pharmaceutical
Hansoh Pharmaceutical
Sanofi
Astrazeneca plc
Novo Nordisk
List of Tables
 Table 1. Global GLP-1RA Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GLP-1RA Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GLP-1RA Therapy Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GLP-1RA Therapy Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GLP-1RA Therapy Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GLP-1RA Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GLP-1RA Therapy Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GLP-1RA Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GLP-1RA Therapy, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1RA Therapy, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1RA Therapy, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1RA Therapy, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1RA Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1RA Therapy as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1RA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GLP-1RA Therapy Sales by Region (2020-2025) & (K Units)
 Table 18. Global GLP-1RA Therapy Sales Market Share by Region (2020-2025)
 Table 19. Global GLP-1RA Therapy Sales by Region (2026-2031) & (K Units)
 Table 20. Global GLP-1RA Therapy Sales Market Share by Region (2026-2031)
 Table 21. Global GLP-1RA Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GLP-1RA Therapy Revenue Market Share by Region (2020-2025)
 Table 23. Global GLP-1RA Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GLP-1RA Therapy Revenue Market Share by Region (2026-2031)
 Table 25. North America GLP-1RA Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GLP-1RA Therapy Sales by Country (2020-2025) & (K Units)
 Table 27. North America GLP-1RA Therapy Sales by Country (2026-2031) & (K Units)
 Table 28. North America GLP-1RA Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GLP-1RA Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GLP-1RA Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GLP-1RA Therapy Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GLP-1RA Therapy Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GLP-1RA Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GLP-1RA Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GLP-1RA Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GLP-1RA Therapy Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GLP-1RA Therapy Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GLP-1RA Therapy Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GLP-1RA Therapy Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GLP-1RA Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GLP-1RA Therapy Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GLP-1RA Therapy Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GLP-1RA Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GLP-1RA Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GLP-1RA Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GLP-1RA Therapy Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GLP-1RA Therapy Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GLP-1RA Therapy Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GLP-1RA Therapy Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GLP-1RA Therapy Sales (K Units) by Type (2020-2025)
 Table 51. Global GLP-1RA Therapy Sales (K Units) by Type (2026-2031)
 Table 52. Global GLP-1RA Therapy Sales Market Share by Type (2020-2025)
 Table 53. Global GLP-1RA Therapy Sales Market Share by Type (2026-2031)
 Table 54. Global GLP-1RA Therapy Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GLP-1RA Therapy Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GLP-1RA Therapy Revenue Market Share by Type (2020-2025)
 Table 57. Global GLP-1RA Therapy Revenue Market Share by Type (2026-2031)
 Table 58. Global GLP-1RA Therapy Price (US$/Unit) by Type (2020-2025)
 Table 59. Global GLP-1RA Therapy Price (US$/Unit) by Type (2026-2031)
 Table 60. Global GLP-1RA Therapy Sales (K Units) by Application (2020-2025)
 Table 61. Global GLP-1RA Therapy Sales (K Units) by Application (2026-2031)
 Table 62. Global GLP-1RA Therapy Sales Market Share by Application (2020-2025)
 Table 63. Global GLP-1RA Therapy Sales Market Share by Application (2026-2031)
 Table 64. Global GLP-1RA Therapy Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GLP-1RA Therapy Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GLP-1RA Therapy Revenue Market Share by Application (2020-2025)
 Table 67. Global GLP-1RA Therapy Revenue Market Share by Application (2026-2031)
 Table 68. Global GLP-1RA Therapy Price (US$/Unit) by Application (2020-2025)
 Table 69. Global GLP-1RA Therapy Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk GLP-1RA Therapy Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca GLP-1RA Therapy Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lily Company Information
 Table 81. Eli Lily Description and Business Overview
 Table 82. Eli Lily GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lily GLP-1RA Therapy Product
 Table 84. Eli Lily Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GSK GLP-1RA Therapy Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi GLP-1RA Therapy Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Shanghai Benemae Pharmaceutical Company Information
 Table 96. Shanghai Benemae Pharmaceutical Description and Business Overview
 Table 97. Shanghai Benemae Pharmaceutical GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Shanghai Benemae Pharmaceutical GLP-1RA Therapy Product
 Table 99. Shanghai Benemae Pharmaceutical Recent Developments/Updates
 Table 100. Hansoh Pharmaceutical Company Information
 Table 101. Hansoh Pharmaceutical Description and Business Overview
 Table 102. Hansoh Pharmaceutical GLP-1RA Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Hansoh Pharmaceutical GLP-1RA Therapy Product
 Table 104. Hansoh Pharmaceutical Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. GLP-1RA Therapy Distributors List
 Table 108. GLP-1RA Therapy Customers List
 Table 109. GLP-1RA Therapy Market Trends
 Table 110. GLP-1RA Therapy Market Drivers
 Table 111. GLP-1RA Therapy Market Challenges
 Table 112. GLP-1RA Therapy Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1RA Therapy
 Figure 2. Global GLP-1RA Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GLP-1RA Therapy Market Share by Type: 2024 & 2031
 Figure 4. Short-acting GLP-1RA Product Picture
 Figure 5. Long-acting GLP-1RA Product Picture
 Figure 6. Global GLP-1RA Therapy Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GLP-1RA Therapy Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global GLP-1RA Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global GLP-1RA Therapy Market Size (2020-2031) & (US$ Million)
 Figure 13. Global GLP-1RA Therapy Sales (2020-2031) & (K Units)
 Figure 14. Global GLP-1RA Therapy Average Price (US$/Unit) & (2020-2031)
 Figure 15. GLP-1RA Therapy Report Years Considered
 Figure 16. GLP-1RA Therapy Sales Share by Manufacturers in 2024
 Figure 17. Global GLP-1RA Therapy Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest GLP-1RA Therapy Players: Market Share by Revenue in GLP-1RA Therapy in 2024
 Figure 19. GLP-1RA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global GLP-1RA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America GLP-1RA Therapy Sales Market Share by Country (2020-2031)
 Figure 22. North America GLP-1RA Therapy Revenue Market Share by Country (2020-2031)
 Figure 23. United States GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe GLP-1RA Therapy Sales Market Share by Country (2020-2031)
 Figure 26. Europe GLP-1RA Therapy Revenue Market Share by Country (2020-2031)
 Figure 27. Germany GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific GLP-1RA Therapy Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific GLP-1RA Therapy Revenue Market Share by Region (2020-2031)
 Figure 34. China GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America GLP-1RA Therapy Sales Market Share by Country (2020-2031)
 Figure 42. Latin America GLP-1RA Therapy Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa GLP-1RA Therapy Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa GLP-1RA Therapy Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE GLP-1RA Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of GLP-1RA Therapy by Type (2020-2031)
 Figure 53. Global Revenue Market Share of GLP-1RA Therapy by Type (2020-2031)
 Figure 54. Global GLP-1RA Therapy Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of GLP-1RA Therapy by Application (2020-2031)
 Figure 56. Global Revenue Market Share of GLP-1RA Therapy by Application (2020-2031)
 Figure 57. Global GLP-1RA Therapy Price (US$/Unit) by Application (2020-2031)
 Figure 58. GLP-1RA Therapy Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Long acting GLP 1RA Market Research Report 2024
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global Short acting GLP 1RA Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global Ultra Long acting GLP 1RA Market Research Report 2024
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1 Drugs Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions